These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 588416)

  • 21. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy.
    Alderton P; Gross J; Green MD
    Cancer Res; 1990 Aug; 50(16):5136-42. PubMed ID: 2116226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.
    Bakowski MT
    Cancer Treat Rev; 1976 Jun; 3(2):95-107. PubMed ID: 821609
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of ICRF-159 or ICRF-186 on cytotoxicity of daunorubicin and doxorubicin.
    Supino R
    Tumori; 1984 Apr; 70(2):121-6. PubMed ID: 6730012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of razoxane (ICRF 159) on daunomycin (NSC 82151) metabolism and DNA complexation.
    Wang GM; Finch M
    Drug Chem Toxicol; 1980; 3(2):213-25. PubMed ID: 7227218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mutagenic activity of razoxane (ICRF 159): an anticancer agent.
    Albanese R; Watkins PA
    Br J Cancer; 1985 Nov; 52(5):725-31. PubMed ID: 3904803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors.
    Ishida R; Miki T; Narita T; Yui R; Sato M; Utsumi KR; Tanabe K; Andoh T
    Cancer Res; 1991 Sep; 51(18):4909-16. PubMed ID: 1654205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between radiation sensitization and DNA damage by bimolane].
    Zhang YP; Chen YN; Fan GC; Xia SX
    Zhongguo Yao Li Xue Bao; 1987 Mar; 8(2):177-80. PubMed ID: 2959009
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibitors of poly (ADP-ribose) synthesis enhance radiation response by differentially affecting repair of potentially lethal versus sublethal damage.
    Ben-Hur E; Utsumi H; Elkind MM
    Br J Cancer Suppl; 1984; 6():39-42. PubMed ID: 6230094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIalpha in vivo.
    Grauslund M; Thougaard AV; Füchtbauer A; Hofland KF; Hjorth PH; Jensen PB; Sehested M; Füchtbauer EM; Jensen LH
    Mol Pharmacol; 2007 Oct; 72(4):1003-14. PubMed ID: 17622580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of trans-cyclopropylbis (diketopiperazine) and chelating agents related to ICRF 159. Cytotoxicity, mutagenicity, and effects on scheduled and unscheduled DNA synthesis.
    Witiak DT; Lee HJ; Hart RW; Gibson RE
    J Med Chem; 1977 May; 20(5):630-5. PubMed ID: 857019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on radiation induction of DNA and chromosome damage and its correlation with cell killing.
    Iliakis G; Kurtzman S; Pantelias G; Okayasu R
    Radiat Res; 1989 Aug; 119(2):286-304. PubMed ID: 2756119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.
    Zupi G; Cavallari A; Greco C; Sacchi A
    Anticancer Res; 1984; 4(1-2):91-5. PubMed ID: 6712181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
    Jensen LH; Dejligbjerg M; Hansen LT; Grauslund M; Jensen PB; Sehested M
    BMC Pharmacol; 2004 Dec; 4():31. PubMed ID: 15575955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice.
    el-Hage A; Herman EH; Yang GC; Crouch RK; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):341-60. PubMed ID: 3090662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of the bis-dioxopiperazines ICRF 159 and ICRF 154 on the urinary excretion of cadmium in cadmium-poisoned rats (author's transl)].
    Witting U; Bertram HP; Schumacher E; Ritter G
    Int Arch Occup Environ Health; 1979 Jan; 42(3-4):365-73. PubMed ID: 217839
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.
    Lu DY; Huang M; Xu CH; Yang WY; Hu CX; Lin LP; Tong LJ; Li MH; Lu W; Zhang XW; Ding J
    BMC Pharmacol; 2005 Jun; 5():11. PubMed ID: 15963241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Holm B; Jensen PB; Sehested M
    Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines.
    Herman EH; Zhang J; Hasinoff BB; Chadwick DP; Clark JR; Ferrans VJ
    Cancer Chemother Pharmacol; 1997; 40(5):400-8. PubMed ID: 9272116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy of a mouse sarcoma using razoxane and electron irradiation.
    Grimshaw MB; Davies RW; Hall WS
    Br J Cancer; 1981 Jul; 44(1):117-23. PubMed ID: 7259958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae.
    Ishida R; Hamatake M; Wasserman RA; Nitiss JL; Wang JC; Andoh T
    Cancer Res; 1995 Jun; 55(11):2299-303. PubMed ID: 7757979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.